成人自身免疫性脑炎的误诊
这项回顾性多中心研究纳入107例被误诊为自身免疫性脑炎(AE)的成人患者,其中77例(72%)不符合AE诊断标准。正确诊断包括功能性神经障碍(25%)、神经退行性疾病(20.5%)、原发性精神疾病(18%)等。提示替代诊断的警示信号包括隐袭起病、非特异性血清抗体阳性及不符合AE诊断标准。
要点
- 107例被误诊为自身免疫性脑炎的患者中,72%不符合AE诊断标准。
- 正确诊断以功能性神经障碍、神经退行性疾病和原发性精神疾病最常见。
- 隐袭起病、非特异性血清抗体阳性及不符合诊断标准提示替代诊断。
核心结论
- 评估自身免疫性脑炎时应考虑广泛的鉴别诊断,误诊可发生于包括专科中心在内的多种场合。
- 提示替代诊断的警示信号包括隐袭起病、非特异性血清抗体阳性及不符合自身免疫性脑炎诊断标准。
- 自身免疫性脑炎误诊可因不必要的免疫治疗导致并发症,并延误正确诊断的治疗。
研究设计与样本
- 回顾性多中心研究,2014年1月1日至2020年12月31日在自身免疫性脑炎亚专科门诊开展,包括Mayo Clinic(n=44)、University of Oxford(n=18)、University of Texas Southwestern(n=18)、University of California, San Francisco(n=17)、University of Washington in St Louis(n=6)和University of Utah(n=4)。
- 纳入标准为年龄≥18岁、在参与中心或其他医疗机构既往诊断为自身免疫性脑炎、随后在参与中心获得替代诊断的成人。
- 共393例患者因自身免疫性脑炎诊断被转诊,其中286例确诊为真性自身免疫性脑炎被排除。
主要发现
- 共107例患者被误诊为自身免疫性脑炎,其中77例(72%)不符合自身免疫性脑炎的诊断标准。
- 中位年龄(IQR)为48(35.5-60.5)岁,女性65例(61%)。
- 正确诊断包括功能性神经障碍(27例[25%])、神经退行性疾病(22例[20.5%])、原发性精神疾病(19例[18%])、合并症所致认知障碍(11例[10%])、脑肿瘤(10例[9.5%)]及其他(18例[17%])。
- 起病为急性/亚急性者56例(52%),隐袭起病(>3个月)者51例(48%)。
- 头颅磁共振提示脑炎者19/104例(18%),脑脊液细胞增多者16/84例(19%)。
临床怎么用
- 评估自身免疫性脑炎时,应考虑广泛的鉴别诊断,包括功能性神经障碍、神经退行性疾病和原发性精神疾病等。
- 注意警示信号:隐袭起病、非特异性血清抗体阳性及不符合自身免疫性脑炎诊断标准,提示应考虑替代诊断。
- 避免过度解读血清抗体阳性及将功能性/精神性或非特异性认知功能障碍误判为脑病,以减少误诊。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Autoimmune encephalitis misdiagnosis can lead to harm. OBJECTIVE: To determine the diseases misdiagnosed as autoimmune encephalitis and potential reasons for misdiagnosis. DESIGN, SETTING, AND PARTICIPANTS: This retrospective multicenter study took place from January 1, 2014, to December 31, 2020, at autoimmune encephalitis subspecialty outpatient clinics including Mayo Clinic (n = 44), University of Oxford (n = 18), University of Texas Southwestern (n = 18), University of California, San Francisco (n = 17), University of Washington in St Louis (n = 6), and University of Utah (n = 4). Inclusion criteria were adults (age ≥18 years) with a prior autoimmune encephalitis diagnosis at a participating center or other medical facility and a subsequent alternative diagnosis at a participating center. A total of 393 patients were referred with an autoimmune encephalitis diagnosis, and of those, 286 patients with true autoimmune encephalitis were excluded. MAIN OUTCOMES AND MEASURES: Data were collected on clinical features, investigations, fulfillment of autoimmune encephalitis criteria, alternative diagnoses, potential contributors to misdiagnosis, and immunotherapy adverse reactions. RESULTS: A total of 107 patients were misdiagnosed with autoimmune encephalitis, and 77 (72%) did not fulfill diagnostic criteria for autoimmune encephalitis. The median (IQR) age was 48 (35.5-60.5) years and 65 (61%) were female. Correct diagnoses included functional neurologic disorder (27 [25%]), neurodegenerative disease (22 [20.5%]), primary psychiatric disease (19 [18%]), cognitive deficits from comorbidities (11 [10%]), cerebral neoplasm (10 [9.5%]), and other (18 [17%]). Onset was acute/subacute in 56 (52%) or insidious (>3 months) in 51 (48%). Magnetic resonance imaging of the brain was suggestive of encephalitis in 19 of 104 patients (18%) and cerebrospinal fluid (CSF) pleocytosis occurred in 16 of 84 patients (19%). Thyroid peroxidase antibodies were elevated in 24 of 62 patients (39%). Positive neural autoantibodies were more frequent in serum than CSF (48 of 105 [46%] vs 7 of 91 [8%]) and included 1 or more of GAD65 (n = 14), voltage-gated potassium channel complex (LGI1 and CASPR2 negative) (n = 10), N-methyl-d-aspartate receptor by cell-based assay only (n = 10; 6 negative in CSF), and other (n = 18). Adverse reactions from immunotherapies occurred in 17 of 84 patients (20%). Potential contributors to misdiagnosis included overinterpretation of positive serum antibodies (53 [50%]), misinterpretation of functional/psychiatric, or nonspecific cognitive dysfunction as encephalopathy (41 [38%]). CONCLUSIONS AND RELEVANCE: When evaluating for autoimmune encephalitis, a broad differential diagnosis should be considered and misdiagnosis occurs in many settings including at specialized centers. In this study, red flags suggesting alternative diagnoses included an insidious onset, positive nonspecific serum antibody, and failure to fulfill autoimmune encephalitis diagnostic criteria. Autoimmune encephalitis misdiagnosis leads to morbidity from unnecessary immunotherapies and delayed treatment of the correct diagnosis.
引用
- Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, et al. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023. PMID: 36441519. doi:10.1001/jamaneurol.2022.4251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。